|
|
|
|
| LEADER |
00000nam a2200000 a 4500 |
| 001 |
4353747 |
| 005 |
20031020115500.0 |
| 008 |
000630s2000 enka 001 0 eng d |
| 003 |
ICU |
| 010 |
|
|
|a 00037101
|
| 015 |
|
|
|a GBA0-44145
|
| 020 |
|
|
|a 0306462222
|
| 035 |
|
|
|a GAEMO44533847-B
|
| 035 |
|
|
|a (GEU-M)(Sirsi)o44533847
|
| 035 |
|
|
|a 90063600
|
| 040 |
|
|
|a UKM
|c UKM
|d NLM
|d OS2
|d MIA
|d OCoLC
|d OrLoB-B
|
| 060 |
1 |
0 |
|a WC 503.2
|b H918 2000
|
| 082 |
0 |
4 |
|a 616.925
|2 21
|
| 245 |
0 |
0 |
|a Human retroviral infections :
|b immunological and therapeutic control /
|c edited by Kenneth E. Ugen, Mauro Bendinelli and Herman Friedman.
|
| 260 |
|
|
|a New York ;
|a London :
|b Plenum Press,
|c c2000.
|
| 300 |
|
|
|a xxii, 368 p. :
|b ill. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Infectious agents and pathogenesis.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g 1.
|t The Two Principal Viremias of HIV: A Comparison of Viral and Host Characteristics /
|r Cynthia L. Bristow --
|g 2.
|t Potential Role of Human T-Cell Leukemia/Lymphoma Viruses (HTLV) in Diseases Other Than Acute T-Cell Leukemia/Lymphoma (ATL) /
|r Teresa C. Gentile and Thomas P. Loughran --
|g 3.
|t Viral-Related Proteins in Immune Dysfunction Associated with AIDS /
|r George J. Cianciolo --
|g 4.
|t Carbohydrate Interactions and HIV-1 /
|r Thomas Kieber-Emmons --
|g 5.
|t HTLV-I and HTLV-II Infection: Immunological and Molecular Aspects /
|r Mosi K. Bennett and Michael G. Agadjanyan --
|g 6.
|t Vaccine Approaches for Human T-Cell Lymphotropic Virus Type I /
|r G. A. Dekaban, A. Peters and J. Arp /
|r [et al.] --
|g 7.
|t Immune Response against HIV-2 /
|r Ewa Bjorling --
|g 8.
|t HIV Mucosal Vaccines /
|r Herman F. Staats and Jerry R. McGhee --
|g 9.
|t Nucleic Acid Vaccination against HIV-I /
|r Ami R. Shah, David B. Weiner and Jean D. Boyer --
|g 10.
|t Passive Immunotherapy against HIV-I: Current Status and Potential /
|r Joseph P. Cotropia and Kenneth E. Ugen --
|g 11.
|t Human Immunodeficiency Virus Type I Accessory Genes: Targets for Therapy /
|r Sagar Kudchodkar, T. Nagashunmugam and Velpandi Ayyavoo --
|g 12.
|t A New Generation of Antiviral Therapeutics Designed to Prevent the Use of Chemokine Receptors for Entry by HIV-1 /
|r Benjamin J. Doranz and Robert W. Doms --
|g 13.
|t Protease Inhibitors and HIV-1 Genetic Variability in Infected Children /
|r Maureen M. Goodenow, Elena E. Perez and John W. Sleasman --
|g 14.
|t Gene Therapy and HIV-1 Infection: Experimental Approaches, Shortcomings, and Possible Solutions /
|r Ralph Dornburg and Roger Pomerantz --
|g 15.
|t Pediatric HIV: Antiretroviral Therapy /
|r Robert P. Nelson, Jr., Patricia J. Emmanuel and Maite De La Morena.
|
| 650 |
|
0 |
|a Retrovirus infections.
|0 http://id.loc.gov/authorities/subjects/sh87006115
|
| 650 |
1 |
2 |
|a HIV Infections
|x therapy.
|
| 650 |
2 |
2 |
|a HIV Infections
|x immunology.
|
| 650 |
|
7 |
|a Retrovirus infections.
|2 fast
|0 http://id.worldcat.org/fast/fst01096403
|
| 700 |
1 |
|
|a Ugen, Kenneth E.
|0 http://id.loc.gov/authorities/names/n00120753
|1 http://viaf.org/viaf/37148661
|
| 700 |
1 |
|
|a Bendinelli, Mauro.
|0 http://id.loc.gov/authorities/names/n88044122
|1 http://viaf.org/viaf/14850873
|
| 700 |
1 |
|
|a Friedman, Herman,
|d 1931-2007
|0 http://id.loc.gov/authorities/names/n79084398
|1 http://viaf.org/viaf/32076813
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)44533847
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 0933d5e3-7efb-504e-8398-f5271f3c9119
|s 2f414c86-2742-50d8-ab0d-74b8a0da4f8b
|
| 928 |
|
|
|t Library of Congress classification
|a QR201.R47 H86 2000
|l JCL
|c JCL-Sci
|i 6383065
|
| 927 |
|
|
|t Library of Congress classification
|a QR201.R47 H86 2000
|l JCL
|c JCL-Sci
|e CRERAR
|b 56454770
|i 6939331
|
